National Storage Mechanism | Additional information
RNS Number : 2457P
Samsung Electronics Co. Ld
16 February 2021
 

Transaction with Affiliate Company

 

Samsung Electronics Co., Ltd. (KS005930, KS005935, SMSN, SMSD) on February 16, 2021

announced that its Board of Directors has authorized the following related-party transaction

with an affiliated company.

 

Trademark License Agreement

-     Grant trademark license to Samsung Biologics

Major Transaction Terms

Transaction Item

License fee for use of trademark

Transaction Date

February 27, 2021

Transaction Period

February 1, 2021-January 31, 2024

Transaction Value

KRW 26,388 million

(total transaction value: KRW 26,388 million)

Contract Type

Negotiated contract

Other information

- The transaction date is the date when the trade license agreement with

  Samsung Biologics was made.

- Transaction period is the contract period.

- The transaction value is an estimate and may change according to

  Samsung Biologics revenue.

* The license fee is set at 0.5% of Samsung Biologics' revenue (excluding

  revenue or purchases not related to the use of trademark) and shall be paid

  every year during the transaction period.

Other Information:

ž Number of Independent Directors Present at the BOD Meeting: 6/6

ž Attendance of Audit Committee: Y

 

This disclosure is in accordance with the Korean Fair Trade Act, which mandates that a company must disclose

     financial and real estate transactions in the event the value of such a transaction is greater or equal to KRW 5 billion

     and the counterparty is a financial affiliate of the party required to make the disclosure.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGPUPUPUPGUBQ